Patient guide · Verified from federal data
Understanding Medicare Part D Prescribing Data
What the numbers reveal about prescribing patterns, and what they do not tell you about provider quality.
The short answer
Part D data shows what a prescriber actually wrote for Medicare patients, claim volume, brand-versus-generic mix, and opioid rates, straight from CMS, with no rating applied.
By the numbers
How large is the Part D prescriber record?
- 7,090,243
- Providers tracked
- 690
- Specialty types
- 56
- States & territories
Medicare Part D prescriber data shows what individual providers prescribe under Medicare, claims, drug costs, and brand-vs-generic ratios. It is the most transparent prescribing dataset in the US, but it covers only Medicare Part D beneficiaries and should not be used as a standalone quality measure. High prescribing volume usually reflects specialty and patient panel size, not overprescribing.
What Part D Data Contains
Each provider row in the Medicare Part D Prescriber Public Use File reports the same set of fields. Here is what each one means, and how to read it: According to the CMS Medicare Part D Prescriber data and the National Provider Identifier Registry, covering 2023 prescribing for more than 1 million U.S. clinicians since the benefit began in January 2006, you can search and compare here, every figure traces to its source in our methodology.
| Field | What it measures | How to read it |
|---|---|---|
| Total claims | Prescriptions + refills billed to Part D | Tracks patient-panel size and specialty, not quality |
| Total drug cost | Gross cost before rebates | Driven by drug mix, not markup by the prescriber |
| Beneficiaries | Distinct Medicare patients served | Claims ÷ beneficiaries ≈ scripts per patient |
| Brand vs. generic | Share of claims for brand-name drugs | National average ≈ 10–15%; higher is normal in specialty care |
| Opioid flags | Opioid claims, cost, and long-acting flag | Expected to be high for pain, oncology, hospice |
For every provider who wrote at least 11 prescriptions under Medicare Part D, the dataset includes their NPI, name, specialty, state, total claims, total drug costs, total days' supply, number of beneficiaries, brand-name claims, generic claims, and opioid prescribing flags.
PlainDoctor integrates this data directly into every provider profile. When you look up a doctor, you can see their total Medicare Part D claims, drug costs, beneficiary count, brand-vs-generic ratio, and top prescribed medications. This data reflects the 2023 calendar year, the most recent release available.
How to Interpret Prescribing Volume
Prescribing volume varies enormously by specialty and practice setting. A primary care physician managing 2,000 Medicare patients may write 15,000 claims per year. A psychiatrist managing medication regimens for 500 patients may write similar numbers. A surgeon who mostly performs procedures may write fewer than 200 claims.
Comparing prescribing volumes across specialties is therefore misleading. The useful comparison is within the same specialty: how does this cardiologist's prescribing pattern compare to other cardiologists in the same state? PlainDoctor shows specialty-level prescribing rankings to enable this comparison. Compare providers within the same specialty using the specialty directory.
Which specialties actually drive Part D
Most large specialties barely touch Medicare Part D
Behavior Technician is the single largest provider specialty in the registry at 545,400 providers, yet only 0% of them appear as Medicare Part D prescribers. Family Medicine Physicians - far from the largest group, are Medicare's prescribing core, with 74.9% active in Part D. Bubble size shows how many providers in each specialty actually prescribe.
Provider headcount vs Medicare Part D participation, by specialty
Read the chart - 28 specialties by Medicare Part D participation
Of the 28 largest provider specialties, 17 have under 5% of their providers active as Medicare Part D prescribers. Source: CMS NPPES registry counts and the Medicare Part D Prescriber dataset.
- Family Medicine Physician 74.9% on Part D 148K providers
- Internal Medicine Physician 74.1% on Part D 173K providers
- Physician Assistant 58.6% on Part D 151K providers
- Family Nurse Practitioner 56.5% on Part D 211K providers
- General Practice Dentistry 56.3% on Part D 122K providers
- Nurse Practitioner 54.5% on Part D 88K providers
- Dentist 53.8% on Part D 94K providers
- Specialist 19.2% on Part D 70K providers
- Pharmacist 11.8% on Part D 291K providers
- Pediatrics Physician 10.4% on Part D 81K providers
- Registered Nurse 9.1% on Part D 177K providers
- Registered Dietitian 0.4% on Part D 65K providers
- Chiropractor 0.3% on Part D 96K providers
- Licensed Practical Nurse 0.3% on Part D 72K providers
- Mental Health Counselor 0.1% on Part D 294K providers
- Physical Therapist 0.1% on Part D 256K providers
- Case Manager/Care Coordinator 0.1% on Part D 161K providers
- Social Worker 0.1% on Part D 140K providers
- Professional Counselor 0.1% on Part D 122K providers
- Counselor 0.1% on Part D 119K providers
- Addiction (Substance Use Disorder) Counselor 0.1% on Part D 110K providers
- Behavior Analyst 0.1% on Part D 97K providers
- Massage Therapist 0.1% on Part D 69K providers
- Behavior Technician 0% on Part D 545K providers
- Clinical Social Worker 0% on Part D 275K providers
- Speech-Language Pathologist 0% on Part D 190K providers
- Occupational Therapist 0% on Part D 129K providers
- Marriage & Family Therapist 0% on Part D 88K providers
Brand-Name vs. Generic Prescribing
Generic drugs are chemically identical to their brand-name counterparts and are approved by the FDA through an Abbreviated New Drug Application (ANDA). They cost 80–85% less on average. When a generic equivalent exists, prescribing it instead of the brand-name version saves money for both the patient and Medicare without affecting treatment efficacy.
A provider's brand-name prescribing percentage is one of the few quality-adjacent metrics available in the data. The national average brand-name rate is roughly 10–15%. Providers with significantly higher brand-name percentages may be prescribing medications that lack generic alternatives (common in oncology and specialty care), treating conditions where specific brand formulations are medically necessary, or not considering cost-effective generic alternatives.
Context matters: a rheumatologist prescribing biologic drugs for autoimmune conditions will naturally show a high brand-name percentage because most biologics have no generic equivalents. This is not poor practice, it reflects the treatment landscape for that specialty.
Brand vs generic, by specialty
How much a specialty prescribes brand-name depends on what it treats
Endocrinology, Diabetes & Metabolism Physicians fill roughly 46% of their Part D claims with brand-name drugs, the newer diabetes and specialty medications they manage have few generics, while dentists sit near <1%, prescribing almost entirely generics. A high brand rate is a property of the conditions treated, not of the prescriber.
- Endocrinology, Diabetes & Metabolism Physician 46%
- Critical Care Medicine (Internal Medicine) Physician 42%
- Pulmonary Disease Physician 40%
- Optometrist 40%
- Ophthalmology Physician 37%
- Radiation Oncology Physician 36%
- Sports Medicine (Orthopaedic Surgery) Physician <1%
- Endodontics <1%
- Oral and Maxillofacial Surgery (Dentist) <1%
- Periodontics <1%
- General Practice Dentistry <1%
- Dentist <1%
Share of each specialty's Medicare Part D claims filled with brand-name drugs, among specialties with at least 2,000 prescribers. Source: CMS Medicare Part D Prescriber data.
The specialty breakdown above shows individual prescribing patterns, but the dataset-wide totals reveal a bigger structural asymmetry: across all 1,370,886 providers in the 2023 Part D dataset, generic drugs account for roughly 84% of every claim filed, yet brand-name drugs still account for roughly 67% of the $274.2 billion in total Part D drug spending. In other words, the vast majority of prescriptions are generic, but a comparatively small share of brand-name prescriptions drives most of the dollar cost, the volume-vs-cost gap that policy discussions about Part D spending are usually about, not the number of pills dispensed.
Opioid Prescribing Flags
The Part D dataset includes specific opioid prescribing indicators: total opioid claims, total opioid drug cost, number of opioid beneficiaries, and a long-acting opioid flag. CMS added these indicators to increase transparency around opioid prescribing patterns following the opioid epidemic.
Opioid prescribing data requires careful interpretation. Pain management specialists, oncologists, and hospice providers prescribe opioids at higher rates as a normal part of their clinical practice. A high opioid claim count from a pain management specialist is expected. A similarly high count from a general practitioner may warrant closer examination, but even then, it may reflect a patient population with high chronic pain prevalence.
What Part D Data Does Not Show
Several important limitations affect how you should use this data:
- Medicare only: Part D data covers only Medicare beneficiaries (primarily people aged 65+ and those with disabilities). It says nothing about a provider's prescribing for commercially insured or uninsured patients, who may represent the majority of their practice.
- No clinical context: The data shows what was prescribed but not why. A provider who appears to prescribe expensive brand-name drugs may be treating patients who failed cheaper alternatives, something the data cannot capture.
- No outcomes: Prescribing data does not indicate whether prescriptions led to good patient outcomes. A provider who prescribes fewer drugs is not necessarily better than one who prescribes more.
- Privacy suppression: Drugs prescribed to fewer than 11 beneficiaries are suppressed, which means the dataset underrepresents low-volume prescriptions and controlled substances with small patient populations.
Using Part D Data Alongside Other Quality Measures
For a fuller picture of provider quality, use Part D prescribing data alongside CMS MIPS (Merit-based Incentive Payment System) scores, which measure quality, cost, improvement activities, and promoting interoperability. PlainDoctor shows MIPS scores when available on individual provider profiles. Together, prescribing patterns and MIPS scores provide two complementary views: what a provider prescribes and how well their overall practice performs on CMS quality measures.
Browse providers by state or search by name in the provider directory to see both prescribing data and quality scores.
Frequently Asked Questions
What is Medicare Part D prescribing data?
Medicare Part D prescribing data is a public dataset released annually by CMS that shows every prescription drug claim submitted under Medicare Part D by individual healthcare providers. It includes the provider's name, NPI number, drug names, total claims, total drug cost, number of beneficiaries, and whether the prescriptions were brand-name or generic.
Does high prescribing volume indicate a problem?
Not necessarily. High prescribing volume typically reflects a large patient panel, a specialty that requires intensive medication management (such as oncology or psychiatry), or a provider who serves a high proportion of Medicare patients. Volume alone is not a quality indicator.
What does the brand vs. generic prescribing ratio mean?
The brand-name prescribing percentage shows what proportion of a provider's claims were for brand-name drugs versus generics. A higher generic rate generally indicates cost-conscious prescribing. However, some conditions require brand-name drugs when generics are not available. The national average is roughly 10–15% brand-name.
Why are some providers' prescribing details suppressed?
CMS suppresses prescribing details when a provider has fewer than 11 beneficiaries for a specific drug, to protect patient privacy. This is common for providers with small Medicare patient panels or who prescribe controlled substances to a small number of patients.
Use Part D data on a real decision
Prescribing patterns are most useful as a conversation starter with your prescriber.
- Look up your prescriber’s Part D profile, their most-prescribed drugs, totals, and how they sit within their specialty. Find a prescriber
- See how prescribing concentrates nationally in the top-100 prescriber tables, with the methodology beside the numbers. Prescriber rankings
- Remember the boundary: Part D covers Medicare prescriptions only, ask your prescriber what their full-practice pattern looks like. Claims-data guide
CMS suppresses low-volume combinations (under 11 beneficiaries) and the public file lags ~18 months, absence of data is not absence of prescribing.
Sources: Centers for Medicare & Medicaid Services, Medicare Part D Prescribers, by Provider and Drug; CMS, Quality Payment Program (MIPS).
Last updated: April 2026
